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Summary Liver and tumour blood flow has been studied in 30 patients with multiple liver metastases and in
14 patients with solitary liver tumours by means of dynamic hepatic scintigraphy. Observations were
compared with those of a group of 33 control subjects. Haemodynamic changes were also measured in 10
patients who underwent hepatic arterial embolization (HAE).
The mesenteric fraction (MF) to tumour regions in 32 subjects showed a wide range compared with control
subjects. In 9 patients the MF to the tumour region was within the normal range suggesting that some
tumours may possess a portal venous supply. The MF to the uninvolved liver regions was below the normal
range in 25% of patients, indicating that HAE could be hazardous in this group. Following HAE the MF
rose in all 4 tumour regions and fell in 4 non-embolized uninvolved liver regions. No increase in colloid
clearance rate (k) was seen though a significant decrease occurred in 4 patients. These changes may well
represent increased portal venous flow into tumours.
The treatment of malignant liver neoplasms, apart from
those that are truly solitary and accordingly suitable for
resection, has been unrewarding in terms of prolonging
survival (Taylor, 1985). Since therapeutic ligation of the
hepatic artery was first performed for a liver tumour
(Reinhoff & Woods, 1953), various forms of hepatic arterial
manipulation have been attempted because tumour neo-
vascularization is predominantly arterial (Breedis & Young,
1954). The hope was that hepatic arterial occlusion might
result in tumour regression and increased survival. Un-
fortunately, initial optimism has largely been unrealized.
Morbidity and mortality associated with the procedures
(Almersjo et al., 1972) as well as the development of arterial
collaterals (Bengmark & Rosengren, 1970) has been
responsible for the limited benefit in terms of survival.
A recent and perhaps more rational method of
dearterialization is by percutaneous radiological hepatic
arterial embolization (HAE). Laparotomy is avoided and
should the vessels recanalise or arterial collaterals develop,
they can be embolized at a later date. Although there is
good evidence that this procedure provides temporary
palliation of symptoms from the carcinoid syndrome
(Odurny & Birch, 1985), the effects on survival have not
been marked, particularly in other types of liver metastases
(Chuang & Wallace, 1981). However, pain due to stretching
of the liver capsule by metastases can sometimes be relieved.
In general, the contribution of the portal vein has largely
been ignored as a potential source of significant tumour
blood flow and nutrition, particularly following de-
arterialisation procedures, principally because of the
difficulty of studying relative hepatic haemodynamics in vivo.
Nevertheless, the portal. venous contribution may be
important, not only for ensuring an adequate supply of the
normal, uninvolved liver but also for providing a potential
blood supply to tumour tissue.
By using the minimally invasive technique of dynamic liver
scintigraphy, a study was undertaken to establish the relative
portal blood flow in tumour and non-tumour liver regions
and the changes that follow HAE in patients with multiple
and solitary malignant tumours.
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Patients and methods
A total of 44 patients with liver tumours were included in
the study. There were 30 patients with multiple liver
metastases, (19 from primary colorectal cancer), seven with
solitary metastases (three from colorectal primaries) and
seven with primary hepatomas of which five also had
cirrhosis. Five patients with multiple metastases underwent
complete HAE and five with solitary tumours had selective
arterial embolization of the tumour only with sparing of the
remaining liver. The data were compared with values
obtained in 33 control subjects. These consisted of 10 fit
healthy volunteers and 23 patients undergoing pre-operative
assessment for suspected intra-abdominal malignancy. Each
of the latter had normal biochemical liver function, a normal
ultrasound examination, no malignancy present at operation
or no evidence of liver disease and remained free of apparent
malignancy for a minimum of 12 months. There were 17
women and 16 men with an age range of 24-80 years.
Dynamic hepatic scanning
The validity of dynamic liver scanning using 99mTc sulphur
colloid has been established in animals (Fleming et al., 1981)
and humans (Fleming et al., 1983).
Each study is performed with the patient fasted overnight
beforehand. A rapid intravenous injection of approximately
150 MBq 99mTc sulphur colloid is given and the subject
imaged anteriorly beneath a large field of view gamma
camera to include the heart, liver, spleen and both kidneys.
The bolus injection was followed by two stage dynamic
computerised acquisition and storage of digital images at
0.5 sec intervals for the first 40 secs (80 images) and
thereafter at 15 sec intervals (60 images). The final image is
equivalent to an anterior image of a static isotope scan. The
first stage acquires the images of the first pass of colloid
through the liver from which the relative arterial and portal
components of regional hepatic blood flow are determined,
whereas, the second measures the rate of colloid clearance
(k) from the whole liver and this is an index of total hepatic
reticuloendothelial blood flow.
Analysis of relative regional bloodflow The end of the first
pass of portal flow (Tp) is separated in time from the end of
the hepatic arterial first pass (Ta) and subsequent
recirculation by using the time activity curves of the heart,
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Figure I Arterial and portal images during first pass of colloid
and final static liver image. Tumour (T) and uninvolved regions
are identified in the final dynamic image and a region of interest
is selected. There is a particularly large 'isotope flush' within the
tumour region in the arterial phase.
spleen and left kidney. The heart peak is taken as zero time
and Ta is derived from the mean of three estimates: firstly,
the time for the heart curve to fall to half of the peak value,
secondly, the time for the spleen curve to reach 85% of the
peak value and lastly, the time of the peak activity of the
kidney curve. The time of the end of portal flow (Tp) is
determined from: time to second peak of heart curve, the
minimal value of the spleen curve after the initial peak and
the time of zero gradient change after the kidney peak. The
mean Ta and Tp are related to the time activity curves of
normal and tumour regions of liver which are identified
from the final image of the dynamic study and constructed
with a light pen. The respective counts of activity (L) are
applied to the formula: MF=L Tp-L TaIL Tp where the
mesenteric fraction (MF) is an index of regional portal
perfusion. Images that correspond with Ta, Tp and the final
image are shown in Figure 1. The metastasis lying in the
lower border of the right lobe has a prominent arterial blush.
Only those tumour regions that were well-defined (identified
by the absence of colloid uptake in the final image) were
used for analysis. Of the seven patients with hepatomas, five
had cirrhosis and the mesenteric fraction of a region
uninvolved by tumour may reflect changes in the relative
haemodynamics incurred by the hepatic parenchyma
(Mclaren et al., 1985).
The mesenteric fraction was measured in normal liver
regions in the control group to obtain the normal range. As
any region suitable for analysis must lie within the right
lobe (regions that overlie the lungs, right kidney or great
vessels are invalidated by the background radiation from
these organs), tumour and normal liver regions could not
always be analysed in the same patient.
Analysis of total hepatic flow The colloid clearance rate (k)
was determined from the time activity curve generated from
a region of interest (ROI) constructed around the whole
liver, using the final image of the study. Each point on the
curve between 2 and 5 min was subtracted from the mean
plateau between 14 and 15 min. The k was derived using
least squares regression on the logarithm of the subtracted
curve. This was measured in all subjects and is strictly an
index of total hepatic reticuloendothelial blood flow.
Hepatic arterial embolisation
Ten patients underwent HAE. Those with multiple
metastases (n =5) had the entire artery embolized, wheras,
those with solitary tumours (n =5) had selective arterial
embolization of the tumour only with sparing of the
remaining liver. The MF was measured in four
nonembolized uninvolved liver regions and four embolized
tumour regions before and after the procedure. Since the
liver has a dual blood supply and compensatory changes in
hepatic blood flow can occur between them following mani-
pulation of either vessel (Richardson & Withrington, 1981),
the changes in the colloid clearance rate were measured in all
10 subjects.
Results
Colloid clearance rate (k)
The mean k of patients with liver tumours was
0.25 +0.05 (s.d.). This was not statistically significantly
different from the control subjects (mean 0.27 +0.07)
(Figure 2).
Mesentericfiraction (MT)
The mesenteric fraction is an indication of relative portal
perfusion. The mean MF recorded in the control group was
0.58 +0.09.
Mesenteric fractions were obtained in 32 tumour regions
and 28 uninvolved liver regions for patients with liver
tumours. The MF for tumour regions showed a very wide
distribution (median 0.23, range: 0.1-0.72) as did the value
in the uninvolved liver region (median 0.60, range: 0.1-0.84)
(Figure 3).
Seventy-two percent of the tumours (23 of the 44 patients)
had a MF below the lower limit of the normal range with 14
recorded as 0.1 (it is not possible to have a value below this
due to statistical errors in the analysis). However, it should
be noted that nine tumour regions (28%), eight of which
were colorectal metastases, had mesenteric fractions within
the normal range. This suggests that the majority of tumours
do obtain a predominant arterial supply but that a
proportion receive an appreciable fraction from the portal
vein.
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Figure 2 The colloid clearance rates in control subjects (Con)
and patients with multiple metastases (MM), single metastases
(SM) and hepatoma (Hep).LIVER TUMOUR BLOOD FLOW 271
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Figure 3 The mesenteric fraction (MF) values in control Pre Post
patients, the tumour and uninvolved tumour regions in patients Embolization
with primary or secondary malignant liver tumours. Regions are
identified as in Figure 1. Figure 4 The mesenteric fraction to uninvolved liver regions before and after selective arterial embolization in 4 patients.
The mesenteric fraction in the uninvolved portion of the
liver was also measured. The values lie in the normal range
(compared to control values) in the majority of patients but
it should be noted that 25% of subjects had mesenteric
fractions below the normal range and in four it was less than
0.15 (Figure 3). This significantly reduced mesenteric fraction
to the uninvolved liver in a proportion of patients with liver
tumours is of importance when arterial embolization is
considered.
Hepatic aterial embolization
The mesenteric fraction to the uninvolved liver in patients
who had selective tumour embolization showed a consistent
fall (Figure 4). However, in patients who underwent
embolization to the liver, the mesenteric fraction increased in
all four tumour regions (Figure 5). There was no change in
the colloid clearance in 6 patients (a change-less than- 0.04 is
within experimental error) but it decreased significantly in
four patients of whom two underwent selective tumour
embolization (Figure 6).
Discussion
It has been generally held that liver tumours obtain a
predominant arterial blood supply with the portal vein
playing little or no part in tumour blood flow and nutrition.
However, in one recent study microfil injected into the portal
vein of autopsy liver specimens showed that 71 out of 83
metastases from different primaries had a portal supply from
the many arterio-portal anastomoses which were present (Lin Po
et al., 1984). In addition, in vivo studies using the xenon Pre Post
clearance technique following hepatic arterial ligation have Embolization
demonstrated an increase in portal venous flow into Figure 5 The mesenteric fraction to the tumour region before
colorectal liver metastases (Taylor et al., 1979). and after total (n =3) and selective (n 1) arterial embolization.
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Figure 6 The colloid clearance rate before and after hepatic
arterial embolization in all 10 patients. A change in the clearance
rate by 0.04 for any individual is significant.
Dynamic liver scintigraphy is a technique which can be
used to study the relative portal flow into different regions
of the liver. This particular technique has been utilized to
measure the effects of cirrhosis on the haemodynamics of the
liver (Mclaren et al., 1985). A variant of the technique has
also been used to evaluate deranged liver blood flow patterns
in the detection of occult hepatic micometastases (Leveson et
al., 1985). Both techniques are dependent on using a limited
ROI within the right lobe to derive an index of relative
perfusion of the whole liver.
The technique is particularly useful in the study of tumour
blood flow since it is non invasive and can be repeated after
HAE. Its limitations are: firstly, imaging is two-dimensional
and overlying normal liver can affect the mesenteric fraction
in a tumour region, secondly, the MF does not reflect the
actual vascularity of the tumours as the fraction is only a
ratio and thirdly, small tumours often cannot be identified
by isotope scanning for analysis and may even be included,
unknowingly, in uninvolved liver regions.
The validity of the method of analysis for determining the
mesenteric fraction in tumour regions is open to criticism as
the formula was originally derived to take into account the
extraction of colloid during the first arterial pass. However,
the error should be small for three reasons: firstly, the
counts of activity at Tp are related only to the first pass of
colboid, secondly, there is likely to be some overlap between
arterial and portal flow at Ta and Tr (especially if tumour
flow is sluggish) and thirdly, overlying normal liver must be
taken into account. Theoretically, the mesenteric fraction of
a tumour region is slightly underestimated.
The range of mesenteric fractions in tumour and
uninvolved liver regions is much wider than the control
group. Seventy-two percent of tumours in this series have a
low mesenteric fraction and this confirms that they have a
predominant arterial blood supply. However, some do have
values within the range seen in normal liver suggesting that
they receive an important portal supply although normal
liver tissue overlying an avascular tumour would produce a
similar result.
The range of the mesenteric fraction noted in the 'normal'
liver regions of patients with tumours was also wide but for
different reasons. Most lie within the normal range as would
be expected, however, there were seven below the lower limit
of the normal range. This would indicate that the portal
perfusion to the functioning liver is severely compromised
either by cirrhosis in the patients with hepatomas, or by
compression of the portal vein by tumour near the hilum
which was confirmed in the four lowest values at laparotomy
or angiography (two of these patients had cirrhosis).
Embolization may result in serious impairment of hepatic
function and even death when the liver is dependent on the
hepatic artery for a blood supply (Chuang & Wallace, 1982;
Sato et al., 1985).
Following HAE, the increase in the mesenteric fraction to
the tumour regions is partly due to their arterial supply
being occluded. It is not possible to determine the extent
that portal flow to tumours contributes to this change, using
tumour regions only. The consistent drop in the mesenteric
fraction in the nonembolized liver regions would favour
portal venous flow increasing to tumours. However,
compensatory haemodynamic changes can take place
between the portal venous and arterial components following
manipulation of either vessel, and these changes in the
mesenteric fraction may be the result. By taking into account
the effects of embolization on total hepatic blood flow, k, it
may be possible to distinguish between compensatory
changes and portal venous flow increasing to tumours.
Those patients who underwent selective tumour embolization
are of particular importance as no part of the reticulo-
endothelial system within the liver was embolized, and the
effects of the procedure on blood flow in the remainder of
the liver will be reflected by the changes in the k. The
significant decrease of k in four patients, two of whom had
the tumour region alone embolized, would suggest that
compensatory changes are minimal. The lack of change in k
in the remaining six patients would be less conclusive that
portal flow increases into tumours following HAE. In
summary, the changes in the mesenteric fraction of all
regions are consistent with an increase in portal flow to the
tumours, though it could only be demonstrated with
certainty in two patients.
These results confirm that the majority of liver tumours
have a predominant arterial blood supply which is reduced
by HAE. However, some tumours may have a significant
portal supply and this is consistent with other recent
observations (Lin et al., 1984, Taylor et al., 1979). The
limited survival benefit achieved with HAE may be partly
explained by this fact. Dynamic liver scintigraphy is a useful
method of recognising patients with restricted portal flow to
the liver who have a risk of liver failure following hepatic
arterial occlusion.
We are most grateful to the Cancer Research Campaign for funding
this study.
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